(2R,3R,4R,6S)-6-{[(3aR,4R,4'R,5'S,6S,6'R,7S,7aR)-6-{[(2S,3R,4S,5S,6R)-2-{[(2R,4S,6S)-6-({(2R,3aS,3a'R,6S,7R,7'R,7aS,7a'S)-7'-[(2,4-二羟基-6-甲基苯甲酰)氧代]-7-羟基八氢-4H-2,4'-螺联[[1,3]二噁唑并[4,5-c]吡喃]-6-基}氧代)-4-羟基-5-甲氧基-2-
- 中文名称:
- (2R,3R,4R,6S)-6-{[(3aR,4R,4'R,5'S,6S,6'R,7S,7aR)-6-{[(2S,3R,4S,5S,6R)-2-{[(2R,4S,6S)-6-({(2R,3aS,3a'R,6S,7R,7'R,7aS,7a'S)-7'-[(2,4-二羟基-6-甲基苯甲酰)氧代]-7-羟基八氢-4H-2,4'-螺联[[1,3]二噁唑并[4,5-c]吡喃]-6-基}氧代)-4-羟基-5-甲氧基-2-
- 中文别名:
- (2R,3R,4R,6S)-6-{[(3aR,4R,4'R,5'S,6S,6'R,7S,7aR)-6-{[(2S,3R,4S,5S,6R)-2-{[(2R,4S,6S)-6-({(2R,3aS,3a'R,6S,7R,7'R,7aS,7a'S)-7'-[(2,4-二羟基-6-甲基苯甲酰)氧代]-7-羟基八氢-4H-2,4'-螺联[[1,3]二噁唑并[4,5-c]吡喃]-6-基}氧代)-4-羟基-5-甲氧基-2-
- 英文名称:
- b-D-Mannopyranoside,O-(1R)-4-O-(2,4-dihydroxy-6-methylbenzoyl)-2,3-O-methylene-D-xylopyranosylidene-(1®3-4)-a-L-lyxopyranosyl O-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-a-L-arabino-hexopyranosyl-(1®3)-O-2,6-dideoxy-4-O-(3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoyl)-b-D-arabino-hexopyranosyl-(1®4)-O-(1R)-2,6-dideoxy-D-arabino-hexopyranosylidene-(1®3-4)-O-6-deoxy-3-C-methyl-b-D-mannopyranosyl-(1®3)-O-6-deoxy-4-O-methyl-b-D-galactopyranosyl-(1®4)-2,6-di-O-methyl-
- 英文别名:
- β-D-Mannopyranoside, O-(1R)-4-O-(2,4-dihydroxy-6-methylbenzoyl)-2,3-O-methylene-D-xylopyranosylidene-(1→3-4)-α-L-lyxopyranosyl O-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-α-L-arabino-hexopyranosyl-(1→3)-O-2,6-dideoxy-4-O-(3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoyl)-β-D-arabino-hexopyranosyl-(1→4)-O-(1R)-2,6-dideoxy-D-arabino-hexopyranosylidene-(1→3-4)-O-6-deoxy-3-C-methyl-β-D-mannopyranosyl-(1→3)-O-6-deoxy-4-O-methyl-β-D-galactopyranosyl-(1→4)-2,6-di-O-methyl-;
Flambamycin, 56-deacetyl-57-demethyl-45-O-de(2-methyl-1-oxopropyl)-12-O-(2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-α-L-arabino-hexopyranosyl)-, 56-(2,4-dihydroxy-6-methylbenzoate);
2,4'-Spirobi[4H-1,3-dioxolo[4,5-c]pyran], flambamycin deriv.;
O-(1R)-4-O-(2,4-Dihydroxy-6-methylbenzoyl)-2,3-O-methylene-D-xylopyranosylidene-(1→3-4)-α-L-lyxopyranosyl O-2,3,6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-α-L-arabino-hexopyranosyl-(1→3)-O-2,6-dideoxy-4-O-(3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoyl)-β-D-arabino-hexopyranosyl-(1→4)-O-(1R)-2,6-dideoxy-D-arabino-hexopyranosylidene-(1→3-4)-O-6-deoxy-3-C-methyl-β-D-mannopyranosyl-(1→3)-O-6-deoxy-4-O-methyl-β-D-galactopyranosyl-(1→4)-2,6-di-O-methyl-β-D-mannopyranoside;
Spiro[4H-1,3-dioxolo[4,5-c]pyran-2,2'-[2H]pyran], flambamycin deriv.;
Antibiotic 13-384-1;
Evernimicin;
Everninomicin;
Everninomicin 13384-1;
Everninomycin;
Sch 27899;
Ziracin
- CAS No.:
- 53024-98-9
- 分 子 式:
-
C70H97Cl2NO38
- 分 子 量:
- 0
- 精确分子量:
- 1629.50658
- 分子结构式:
-

- SDS:
- 查看
(2R,3R,4R,6S)-6-{[(3aR,4R,4'R,5'S,6S,6'R,7S,7aR)-6-{[(2S,3R,4S,5S,6R)-2-{[(2R,4S,6S)-6-({(2R,3aS,3a'R,6S,7R,7'R,7aS,7a'S)-7'-[(2,4-二羟基-6-甲基苯甲酰)氧代]-7-羟基八氢-4H-2,4'-螺联[[1,3]二噁唑并[4,5-c]吡喃]-6-基}氧代)-4-羟基-5-甲氧基-2- 分子结构与计算化学数据
计算化学数据
1.疏水参数计算参考值(XlogP):1.5
2.氢键供体数量:8
3.氢键受体数量:38
4.可旋转化学键数量:22
5.互变异构体数量:300
6.拓扑分子极性表面积:482
7.重原子数量:111
8.表面电荷:0
9.复杂度:3160
10.同位素原子数量:0
11.确定原子立构中心数量:32
12.不确定原子立构中心数量:3
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1